Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

Martin Peifer, Lynnette Fernandez‐Cuesta, Martin L. Sos, +89

Nature Genetics

EngineeringSomatic VariantTumor HeterogeneityMedicineGenetics +8

Frequent and Focal <i>FGFR1</i> Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

Jonathan M. Weiss, Martin L. Sos, Danila Seidel, +59

Science Translational Medicine

Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification

Prudence A. Russell, Zoe Wainer, Gavin Wright, +3

Journal of Thoracic Oncology

Advanced Lung DiseaseMedicinePathologyCancer PrognosisNew International Association +6

Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids

Lynnette Fernandez‐Cuesta, Martin Peifer, Xin Lü, +43

Nature Communications

ChromatinFrequent MutationsGeneticsBronchial NeoplasmPulmonary Blastoma +5

<i>CD74–NRG1</i> Fusions in Lung Adenocarcinoma

Lynnette Fernandez‐Cuesta, Dennis Plenker, Hirotaka Osada, +48

Cancer Discovery

Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization

Christina Selinger, Toni-Maree Rogers, Prudence A. Russell, +11

Modern Pathology

MedicineAlk RearrangementLung AdenocarcinomaPathologyBronchial Neoplasm +6

Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients

Prudence A. Russell, Stephen Barnett, Marzena Walkiewicz, +8

Journal of Thoracic Oncology

Somatic VariantCancer PathologyMedicinePathologyBronchial Neoplasm +8

Comparison of Methods in the Detection of ALK and ROS1 Rearrangements in Lung Cancer

Toni-Maree Rogers, Prudence A. Russell, Gavin Wright, +9

Journal of Thoracic Oncology

Cancer DetectionOncogenic AgentMedicinePathologyBronchial Neoplasm +5

The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer

Muhammad Alamgeer, Vinod Ganju, Anette Szczepny, +9

Thorax

Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data

Lynnette Fernandez‐Cuesta, Ruping Sun, Roopika Menon, +37

Genome Biology